SPRIX (ketorolac nasal spray)

SELF-ADMINISTRATION - NASAL

Indications for Prior Authorization
  • Indicated in adult patients for the short term (up to 5 days) management of moderate to moderately severe pain that requires analgesia at the opioid level.
Patient must meet the following criteria for the indication(s) above:
  • The patient is being treated for acute pain, AND
  • The patient experienced an inadequate treatment response or intolerance to an oral generic ketorolac product OR the patient is unable to swallow oral medications, AND
  • The patient will be treated for less than or equal to 5 days
Dosing:
  • The total duration or use of Sprix® alone or sequentially with other formulations of ketorolac (IM/IV or oral) must not exceed 5 days due to the potential for increasing the frequency and severity of adverse reactions associated with the recommended doses.
  • Sprix® cannot be used concomitantly with other formulations of ketorolac or other NSAIDs.
Approval:
  • 5 days maximum supply.

Last review date: April 16, 2019

Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone